In the closing of the recent trading day, Merck (MRK) stood at $94.71, denoting a +1.46% change from the preceding trading day.

DelveInsight recently conducted an in-depth MASH Market Size and Share Assessment to help a pharmaceutical client understand the ...

NEW YORK, NY / ACCESS Newswire / March 13, 2025 / Bionoid Pharma, Inc. ("Bionoid") is pleased to announce the successful completion of its financial audits for the fiscal years 2022 and 2023 by ...

Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

Ireland hosts the world's ten largest drugmakers, including U.S. companies Johnson & Johnson, Pfizer, and Merck, all of which have large plants on the Emerald Isle. But for how long?

Novo Nordisk NVO announced disappointing data from a phase III study on a novel obesity candidate, CagriSema. Roche RHHBY ...

Merck's stock dropped 1.37% in the latest session, underperforming the S&P 500’s 0.49% gain. Despite this, Merck has surged 9 ...

Shares of Viking Therapeutics VKTX gained more than 11% on Wednesday after the company announced that it had signed a broad ...

Exelixis' future depends on trial outcomes and patent risks. Find out why EXEL stock is a "Sell" despite cabozantinib's ...

Michael Castagna became CEO of MannKind and joined its board of directors in 2017, bringing 25+ years’ experience in ...

A significant proportion of employment, tax receipts and exports all directly dependent on a cluster of US multinational ...